Warning: Missing argument 2 for wpdb::prepare(), called in /home4/bquality/public_html/wp-content/plugins/membership/membershipincludes/classes/membershippublic.php on line 2303 and defined in /home4/bquality/public_html/wp-includes/wp-db.php on line 1290

Warning: Missing argument 2 for wpdb::prepare(), called in /home4/bquality/public_html/wp-content/plugins/membership/membershipincludes/classes/membershippublic.php on line 2303 and defined in /home4/bquality/public_html/wp-includes/wp-db.php on line 1290
Spanish regulators review European regulatory landscape for cancer vaccines | BioQuality.biz

Cancer immunotherapy products: Regulatory aspects in the European Union.

Hum Vaccin Immunother. 2012 Sep 1;8(9). [Epub ahead of print], Camarero J, Ruiz S., Spanish Medicines Agency; Pharmacology and Clinical Assessment Division; Madrid, Spain.

Synopsis

  • Cancer vaccines, also known as active immunotherapy products are products whose mode of action is to evoke an immune response designed to cause tumor destruction or at least reduce the progression of the tumor.
  • The nature of these products results in certain challenges and difficulties:
    • Quality attributes of these products can be difficult to characterize
    • There is typically a high variability in measurement of quality and other attributes
    • This is especially so for autologous therapies
    • The above complicate interpretation of clinical data
  • Another difficulty according to the authors are the “questions arise in the evaluation of efficacy and safety data in comparison with current chemical or biological treatments for the same indications.”
  •  This review explores the European Union regulatory requirements for such products
  •  Two products, both of which are considered therapeutic cancer vaccines, recently assessed by the regulators are used as examples: Oncophage, for renal cell carcinoma and Provenge, for prostate cancer

To see the Abstract, and a link to obtain this paper: http://www.ncbi.nlm.nih.gov/pubmed/22863755

Take a look at all the topics we research every month for our Literature Search, our Stories, and our Current Awareness Features, and if you don’t see a topic of major interest to you, send me an email [biotext1ster@gmail.com] or text me @ 951-323-4215 and I will add it if it is appropriate to our editorial scope, which is any topic related to the quality, safety, efficacy, or availability of biopharmaceuticals and biologics.

Our Current Search Topics

Access to Medicines

ADME/DMPK  [absorption, distribution, metabolism, and elimination/ drug metabolism and pharmacokinetics]–New! thanks to the reader who suggested this topic

Adverse Event Monitoring and Reporting

Analytical Methods for Characterization and Control

Anti-drug Antibodies and Unwanted Immunogenicity

At the Cutting Edge

Basic Science Relevant to Biopharma and Biologics

Bioanalytical Methods and Issues

Biological Potency, Activity, and other Biological Assays

Biomarkers

Biosimilars, Follow-on Biologics, FOPPs, Biobetters, etc.

Carbohydrate/Glycan/Oligosaccharide/Polysaccharide Characterization and Analysis

Cellular Therapies and Regenerative Medicine

Clinical Issues

Combination Products– New! thanks to the reader who suggested this topic

Container/Closure Issues

Data Analysis, Mathematical Models and Statistics

Development Costs

Development Issues, Concerns, Strategies, etc.

Deviations, Handling and Reporting

Discovery Research

Distribution Issues

European Regulations and Regulatory Perspective

Excipient Analysis and Control

Formulation and Delivery

Gene and other Nucleic Acid Therapy

General Business Issues

GMP Compliance, General

Good Distribution Practice

Host Cell Proteins

Imaging–New! thanks to the reader who suggested this topic

Laboratory Issues

Manufacturing and Production Issues

Method Qualification and Validation

Microbial Analysis and Control

Molecular and Personalized Medicine

Nanomedicine and Biopharmaceuticals– New! thanks to the reader who suggest this topic

Nucleic Acids

Particulate Analysis and Issues

Personalized and Molecular Medicine

Preclinical Issues

Process Monitoring, and Control, Process Analytical Technology (PAT)

Process Development

Product Development, Pre-clinical and Clinical

Protein, Glycoprotein, Peptide, and Other Bio-molecule Structure/Function

Proteins, Glycoproteins, Peptides, Antibodies and Other Biomolecules: Characterization, Analysis, and Control

Quality by Design (QbD)

Raw Material Analysis and Control

Regenerative Medicine

Regulations, General Considerations

Regulatory Agencies

Regulatory Submissions, Review, Reporting, etc.

Reference Standard Qualification and Verification

Risk Analysis and Management

Safety and Efficacy Issues

Separation Science

Stability, Aggregation, and Degradation Issues

Surveillance and Pharmacovigilance

Vaccine Development, Testing, Control, Production, Delivery, Stability

Validation

 

BioQuality, just what you need to know when you need to know it

Comments

Post a comment

You must be logged in to post a comment.

BioQuality.com. Copyright © 2015. All rights reserved.
Turning Information into Practical Knowledge